Abstract:Background Choriocarcinoma is a highly aggressive, malignant trophoblastic neoplasm that can be gestational or non-gestational in origin. Accurate discrimination between these two subtypes, the causative pregnancy type, and the pregnancy-to-treatment interval for gestational choriocarcinoma are vital for clinical management. Methods Fifteen choriocarcinomas were genotyped using multiplex fluorescent polymerase chain reaction amplification of 15 short tandem repeat (STR) loci and the amelogenin locus (XY determination). Genotype patterns at each locus from tumoral and maternal tissues were compared, and any prior or concurrent mole/placenta was also compared when available. According to STR results showing the presence or absence of the paternal chromosomal complement, the gestational or non-gestational origin of the tumor and the nature of the causative pregnancy was identified. Results Fourteen tumors were gestational. Of these, seven were androgenetic/homozygous XX, and two were androgenetic/heterozygous XX, indicating that the causative pregnancies were molar pregnancies. Among the nine molar pregnancies, five were of the occult type. A menopausal patient developed a tumor from a mole that occurred seven years ago, identified by the genetically identical allele from the tumor and prior mole. One tumor originating from a previous mole was interrupted by term delivery. Two tumors found eight weeks postpartum were identified as originating from a prior occult mole. A pelvic choriocarcinoma was separated from a genetically distinct third trimester intrauterine placenta. Five gestational tumors were biparental: 2 XX, 3 XY. Of three ovarian tumors, two were confirmed gestational (1 androgenetic/homozygous XX; 1 biparental XY), and one was an ovarian tumor (XX) with a complete match of the genotype for all 15 loci, therefore ascertaining its non-gestational origin. Conclusion Gestational choriocarcinoma can originate in an androgenetic or biparental manner. The majority are androgenetic/homozygous XX, while a large number of them might be occult molar pregnancies. The origin of ectopic androgenetic choriocarcinoma with concurrent intrauterine placenta might be from either dispermic twin gestation (mole and coexistent nonmolar fetus) or an antecedent molar pregnancy. Choriocarcinoma shortly postpartum might not be associated with the last placenta. STR analysis can be useful in distinguishing gestational choriocarcinoma from non-gestational, as well as the causative pregnancy, and serve as a helpful examination tool for guiding clinical management.

[Molecular Pathological Diagnosis of Twin Pregnancy with Complicated Genetical Characteristics].

Challenges in Diagnosing Hydatidiform Moles: a Review of Promising Molecular Biomarkers.

Twin Pregnancy with Complete Hydatidiform Mole and Co-Existing Fetus: A Report of 15 Cases with a Clinicopathological Analysis and DNA Genotyping.

Enhancing Clinicopathological Diagnosis of Hydatidiform Mole Through the Combined Application of Histomorphologic Analysis, Immunohistochemical Analysis of p57 Expression, and Short Tandem Repeat Typing Method

Twin pregnancy consisting of a complete hydatidiform mole and coexistent fetus: a clinicopathological analysis

Hematoxylin and Eosin Staining Helps Reduce Maternal Contamination in Short Tandem Repeat Genotyping for Hydatidiform Mole Diagnosis.

Application of Short Tandem Repeat (STR) Genotyping in Partial Hydatidiform Mole.

Twin/Multiple Gestations With a Hydatidiform Mole: Clinicopathologic Analysis of 21 Cases With Emphasis on Molecular Genotyping and Parental Contribution

Analysis of Gestational Trophoblastic Disease by Genotyping and Chromosome in Situ Hybridization.

Using Short Tandem Repeat Analysis for Choriocarcinoma Diagnosis: a Case Series

Single‐nucleotide polymorphism array and fluorescence in situ hybridization analysis to decode the cytogenetic profile of atypical partial hydatidiform moles diagnosed by short tandem repeat polymorphism analysis

STR DNA Genotyping of Hydatidiform Moles in South China.

[Clinical application of STR genotyping diagnosis for hydatidiform mole and nonmolar gestation]

Evaluation of Combined p57KIP2 Immunohistochemistry and Fluorescent in situ Hybridization Analysis for Hydatidiform Moles Compared with Genotyping Diagnosis

[Study on Parental Origin of Complete Hydatidiform Mole Detected by Polymorphisms of Microsatellite].

Roles of P57kip2 Immunohistochemistry and Flow Cytometry in Diagnosis of Molar Pregnancy

Expression of KCNQ1 and P57kip2 and Their Clinical Significance in Hydatidiform Mole

Application of P57 immunohistochemistry and CEP17 ploidy analysis in differential diagnosis of hydatidiform mole

Combination of Laser Capture Micro-Dissection(lcm) and Short Tandem Repeats(str) Polymorphisms in Determination of Fertilization Types of Gestational Trophoblastic Disease

PTEN Promoter Methylation and Protein Expression in Normal Early Placentas and Hydatidiform Moles

The diagnostic value of Ki-67, P53 and P63 in distinguishing partial Hydatidiform mole from hydropic abortion